Related Experiment Video
Updated: May 24, 2026

06:48
Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
Published on: January 7, 2019
Comparison of Loss Functions for Fibroglandular Tissue Segmentation in MRI.
Alexia Rizoudis1, Ramona Wudy2, Carl Mathis Wild3
1IT-Infrastructure for Translational Medical Research, University of Augsburg, Germany.
Studies in Health Technology and Informatics
|May 23, 2026
Summary
Choosing the right loss function for breast MRI segmentation is complex. Standard Dice + cross-entropy loss performed best for segmenting breast, fibroglandular tissue (FGT), and implants, outperforming novel Skeleton Recall Loss (SRL) and Volume-Aware Loss (VAL).
Area of Science:
- Medical Imaging
- Radiology
- Artificial Intelligence in Medicine
Background:
- Accurate segmentation of breast, fibroglandular tissue (FGT), and implants in MRI is crucial but challenging due to anatomical variability and imaging heterogeneity.
- Loss functions significantly impact segmentation performance in medical imaging tasks.
Purpose of the Study:
- To compare the efficacy of three distinct loss function strategies for segmenting breast, FGT, and implants in breast MRI.
- To evaluate a baseline Dice + cross-entropy loss, Skeleton Recall Loss (SRL), and a novel Volume-Aware Loss (VAL).
Main Methods:
- Utilized 136 pre-contrast T1-weighted breast MRI volumes.
- Implemented a 5-fold cross-validation approach.
- Compared segmentation performance using Dice Similarity Coefficient (DSC) for breast, FGT, and implants.
Main Results:
- The baseline model with Dice + cross-entropy loss achieved the highest overall performance (mean DSC: 0.921 breast, 0.712 FGT, 0.933 implant).
- Skeleton Recall Loss (SRL) and Volume-Aware Loss (VAL) showed comparable performance to the baseline within statistical variance.
- No significant improvement was observed with SRL or VAL over the standard approach in this dataset.
Conclusions:
- The standard Dice + cross-entropy loss function is the current gold-standard for heterogeneous breast MRI segmentation.
- Novel loss functions like SRL and VAL did not demonstrate superior performance in this specific application.
- Further research may be needed to optimize SRL and VAL for complex medical imaging segmentation tasks.

